[24] Adequate bowel length was preserved in infants with massive intestinal necrosis, allowing for their survival. There was no major morbidity in study infants, and only 30% required a second ...

Infliximab is a chimeric monoclonal antibody against tumour-necrosis factor-α (TNF-α ... Targan, M.D., Director, at the Cedars-Sinai Inflammatory Bowel Disease Center, UCLA School of Medicine ...

No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.